DFE Pharma

Indoco Remedies Ltd., headquartered in Mumbai, is a fully integrated, research-oriented Pharma Company with presence in 55 countries. Indoco, a USD 166 million company, employs over 6000 people including over 300 skilled scientists.

The Company has 9 manufacturing facilities, 6 for FDFs and 3 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. The facilities have been approved by various regulatory authorities such as USFDA, UK-MHRA, DRU Botswana, PMDA-Japan, TGA-Australia, FMHACA-Ethiopia, DPML- Ivory Coast, SAHPRA- South Africa, NDA-Uganda, etc.

Indoco has 9 domestic marketing divisions with a strong brand portfolio in various therapeutic segments including Gastro-intestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals,  Cardiovascular, Anti-Diabetics, Pain Management  etc. Top Indoco brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital,  Sensoform, Sensodent-KF, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM, Methycal, etc. On the international front, Indoco has tie-ups with large generic companies across the globe.

Indoco has carved a place for itself in the international arena and is exporting a number of generic products in the Regulated and Emerging Markets. Indoco’s branded formulations are promoted in Emerging Markets of South East Asia, Africa, Latin America and CIS countries. The Company participates in various tenders floated by authorities from different countries. Indoco has tie-ups with large generic companies across the globe and works in close coordination with its customers for leveraging core competencies.

Indoco Analytical Solutions division has been carved to serve customers for their analytical research needs. AnaCipher CRO, Hyderabad, is a USFDA inspected facility providing clinical trial solutions, BA/BE/Phase I/Phase studies.

RPG Life Sciences, a part of RPG Enterprises, is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations, Global Generics, Synthetic and Fermentation APIs space. The company is a research based pharmaceutical company, producing a wide range of quality, affordable medicines. Our brands are highly trusted by healthcare professionals and patients. Customer satisfaction is fundamental to the company.

RPG Life Sciences is focused on exploring new ways to facilitate access to safe and affordable medicines. It is a niche developer of pharmaceutical products, operating primarily in a broad range of branded formulations, generic dosage forms and APIs developed through synthetic routes.

Azathioprine, a flagship product of RPG Life Sciences has dominant market share worldwide in immunosuppressant therapy. The domestic business has the major presence in therapies like gastrointestinal, pain management, cardiovascular, nephrology, vitamins, respiratory therapy, antacid & urology with legendary brands like Lomotil, Lomofen, Naprosyn, Azoran, Aldactone and Serenace, Minmin Tonic, Romilast, Tricaine, Sildura.

A trusted name the world over, RPG Life Sciences has a global map of satisfied customers and continues to provide an accessible passage to quality healthcare through rigorous innovations and growing international partnerships.

With manufacturing facilities located in Ankleshwar, Gujarat and Navi Mumbai, Maharashtra, RPG Life Sciences is a company that is growing from strength to strength to capture the enormous opportunities that the pharmaceutical space offers. These facilities have been approved by various regulatory bodies.

Altiora is a full service Contract Research Organization (CRO). based in Zagreb, Croatia and operating throughout Central and Eastern Europe. We conduct phase I – IV clinical trials for multinational pharmaceutical and biotechnology firms, as well as providing a broad range of related services, such as Regulatory, PV and Medical Writing.

Our goal is deliver the best service and quality to our customers while ensuring the well-being of trial subjects through our commitment to international regulatory stands.

We therefore chose Altiora as our name, since this word is derived from the Latin word Alt (Altior) - high (higher). Our motto is "Ad Altiora"​ in other words 'to strive for the highest'​

Altiora has a broad range of therapeutic experience, Including Biosimilars, Oncology, CVS, CNS GI, Respiratory, Pain, Metabolism and Nephrology. Our patient recruitment rates are high and our commitment to staff training and quality ensure our standards remain high throughout all stages of our clients'​ clinical studies. This is reflected in our high customer service feedback - almost 90% satisfaction.

Chiesi is an international company originated in Parma, with 85 years of experience and a strong focus on research, development, production and commercialization of innovative therapeutic solutions in the Respiratory, Neonatology, Rare Diseases and Special Care Therapeutic Areas. We are value-oriented, passionate, supportive and a global family with nearly 6.000 employees and 29 affiliates who have a real impact on people's lives in 90 countries around the world. With a turnover of nearly €2 billion sales, we are among the top 50 pharmaceutical companies in the world.
Chiesi is the largest global pharmaceutical Group to be awarded B Corp Certification, a recognition of high social and environmental standards. We want to use business as a force for good and create a positive impact on people, environment and community.

See our community guidelines: https://www.chiesi.com/en/linkedin-community-guidelines/

Cliantha Research, full-service Clinical Research Organization (CRO), provides comprehensive and integrated offerings in Early Phase (BA-BE & Phase I), Late Phase (II-IV), Respiratory, Tobacco Research, Dermatology, Consumer Research, Research, Lab services, IVRT, Biometrics, Medical Services, Environmental Exposure Chambers (EECs).

Cliantha, by leveraging on the depth of experience provides ethical, value added customer centric services rooted in excellence, thereby enabling clinical development of pharmaceutical, biotech & healthcare companies.

With strategic acquisitions globally, Cliantha has widened the horizon of clinical research & support services for end-to-end developmental needs all across. The company merged its group companies Inflamax Research, Hilltop Research, and Solvius LLP under one flagship brand – Cliantha.

With several advanced clinical sites and bio-analytical laboratories in North America and India, Cliantha now has presence in 4 countries along with a strong team of 1000+ professionals. Some of the key regulators, such as the USFDA, EMA, AGES, ANSM, AMPS, MCC South Africa, Health Canada, DCGI, CAP, NABL, Turkey MOH, Thailand MoPH and others have successfully inspected Cliantha across the globe.

Cliantha Research is headquartered in Ahmedabad and has expanded its domestic reach with 5 regional offices & has presence in USA (Florida & New Jersey), Canada (Mississauga, Winnipeg & Scarborough) & Europe (Portugal)